United Kingdom· GB-APID-7577611000001103
WinRho SDF 1,500unit powder and solvent for solution for injection vials
A medicinal product containing anti-d immunoglobulin, registered in United Kingdom by Baxter Healthcare Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Anti-D immunoglobulin
- Manufacturer
- Baxter Healthcare Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Anti-d immunoglobulin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandRhesonativOctapharma Ab
- United StatesHYPERRHOGRIFOLS USA, LLC
- NetherlandsRhesonativ 625 IE/ml, oplossing voor injectieOctapharma GmbH
- PolandGamma anty-D 150Synthaverse S.A.
- BelgiumImmunorho 300 µg/2 mlKedrion
- CzechiaIGAMADInstituto Grifols, S.A., Barcelona
- ItalyIGAMAD*1 fiala IM 1.500 UI + 1 fiala solv 2 mlINSTITUTO GRIFOLS S.A.
- SwedenRhesonativ 625 IE/ml Injektionsvätska, lösningOctapharma AB
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Rhesonativ, Rhophylac
- Belgium · Immunorho, Rhophylac
- Bulgaria · Резонатив
- Cyprus · Rhesonativ, Rhophylac
- Czechia · Igamad, Rhesonativ
- Germany · Rhesonativ, Rhophylac
- Denmark · Rhesonativ, Rhophylac
- Estonia · Rhesonativ
- Spain · Igamad, Rhophylac
- Finland · Rhophylac
- France · Rhesonativ, Rhophylac
- Greece · Rhophylac
- Hungary · Rhesonativ, Rhophylac
- Ireland · Rhophylac
- Iceland · Rhesonativ, Rhophylac
- Italy · Igamad, Immunorho
- Lithuania · Rhesonativ
- Luxembourg · Rhesonativ, Rhophylac
- Latvia · Rhesonativ
- Malta · Rhesonativ, Rhophylac
- Netherlands · Rhesonativ, Rhophylac
- Norway · Rhesonativ, Rhophylac
- Poland · Gamma Anty-D, Rhesonativ
- Portugal · Rhesonativ, Rhophylac
- Romania · Rhesonativ, Rhophylac
- Sweden · Rhesonativ, Rhophylac
- Slovenia · Rhesonativ, Rhophylac
- Slovakia · Igamad, Rhesonativ
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e89ac5ce-00c7-46dc-ac60-4d0cb9d4a7c9 GET /v1/drugs/e89ac5ce-00c7-46dc-ac60-4d0cb9d4a7c9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "7577611000001103",
"desc": "WinRho SDF 1,500unit powder and solvent for solution for injection vials (Baxter Healthcare Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "13340711000001104",
"source": "dmd",
"vtm_id": "42638611000001105",
"strength": "1500 unit",
"substance": "Anti-D immunoglobulin",
"ingredient": "Anti-D (RHO) immunoglobulin",
"supplier_code": "2063601000001104"
}See everything about anti-d immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.